查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1593740

全球鎮痛藥市場評估：依藥物類別、給藥途徑、應用、通路、地區、機會、預測（2017-2031）

Analgesics Market Assessment, By Drug Class, By Route of Administration, By Application, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 246 Pages | 商品交期: 3-5個工作天內

價格

全球止痛藥市場規模預計將從 2023 年的 374.2 億美元增至 2031 年的 603.7 億美元，預計 2024-2031 年的複合年增長率為 6.16%。對止痛藥的需求不斷增加可歸因於老年人口的迅速增長、慢性病和殘疾的患病率不斷增加，以及對治療各種疾病的手術幹預的需求不斷增加。為了確保患者的身心健康並使其恢復日常生活，對包括子宮切除術在內的各種手術的需求不斷增長，導致全球範圍內需要鎮痛藥來控製手術相關的疼痛，這是市場需求增加的主要因素之一。經腹子宮切除術是美國最常進行的婦科手術。

此外，慢性病和殘疾盛行率的上升也推動了全球止痛藥市場的成長。患有終生慢性病的患者通常更喜歡非侵入性替代方案來有效控制疼痛，因為經常需要適當的治療。非侵入性鎮痛為患者提供了易用性，對於患者需要頻繁緩解疼痛的情況至關重要。另一方面，老年人口的增加也推動了止痛藥市場的需求。這是因為人口老化更容易因缺乏協調而生病和受傷。

此外，世界各國政府和監管機構越來越多地推動非阿片類止痛藥的開發，以取代傳統上用於控製手術和慢性病疼痛的阿片類止痛藥，這對市場擴張產生了積極影響。 2022 年 2 月，美國食品藥物管理局 (FDA) 宣佈了新措施，以減少阿片類藥物暴露並鼓勵開發非成癮性鴉片類藥物替代品來治療急性疼痛。作為美國衛生與公眾服務部應對阿片類藥物危機五點策略的一部分，FDA 正在從各個方面應對這一流行病，採取措施鼓勵適當的處方並加速開發改進的止痛解決方案。新的成癮並減少阿片類藥物的接觸。

本報告研究和分析了全球止痛藥市場，提供市場規模和預測、市場動態以及主要參與者的狀況。

目錄

第1章專案範圍與定義

第2章研究方法

第 3 章執行摘要

第4章全球鎮痛藥市場展望（2017-2031）

  • 市場規模分析與預測
    • 金額
  • 市佔率分析與預測
    • 依藥物類別
    • 依給藥途徑
    • 依用途
    • 按分銷管道
    • 按地區
    • 市佔率分析：按公司劃分（金額）（前 5 名公司及其他 - 2023 年）
  • 市場地圖分析（2023 年）
    • 依藥物類別
    • 依給藥途徑
    • 依用途
    • 按分銷管道
    • 按地區

第5章北美鎮痛藥市場展望（2017-2031）

  • 市場規模分析與預測
    • 金額
  • 市佔率分析與預測
    • 依藥物類別
    • 依給藥途徑
    • 依用途
    • 按分銷管道
    • 分享：依國家/地區
  • 每個國家市場的評估
    • 美國止痛藥市場前景（2017-2031）
    • 加拿大
    • 墨西哥

第6章歐洲鎮痛藥市場展望（2017-2031）

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第7章亞太鎮痛藥市場展望（2017-2031）

  • 印度
  • 中國
  • 日本
  • 澳大利亞
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第8章南美洲鎮痛藥市場展望（2017-2031）

  • 巴西
  • 阿根廷

第9章中東和非洲鎮痛藥市場展望（2017-2031）

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 以色列

第10章供需分析

第11章進出口分析

第12章價值鏈分析

第 13 章波特五力分析

第14章PESTLE分析

第15章價格分析

第 16 章市場動態

  • 市場驅動因素
  • 市場課題

第17章市場趨勢與發展

第 18 章監理架構與創新

  • 臨床試驗
  • 監理機關的核准

第19章專利狀況

第 20 章個案研究

第21章競爭態勢

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名的公司的 SWOT 分析
  • 前10名主要企業狀況
    • AbbVie Inc.
    • Pfizer Inc.
    • Endo, Inc.
    • Eli Lilly and Company
    • Bayer AG
    • Abbott Laboratories
    • Johnson & Johnson Services, Inc. (Janssen Global Services, LLC)
    • GlaxoSmithKline plc
    • Teva Pharmaceutical Industries Ltd.
    • Groupe Sanofi

第22章策略建議

第23章關於我們公司，免責聲明

Product Code: MX12251

Global analgesics market is projected to witness a CAGR of 6.16% during the forecast period 2024-2031, growing from USD 37.42 billion in 2023 to USD 60.37 billion in 2031. The rising requirement for analgesics can be attributed to the rapid growth of the geriatric population, increasing incidences of chronic diseases and disorders, and the growing requirement for surgical intervention for treating various conditions. The rising requirement for different surgical procedures, including hysterectomies, to ensure the health and well-being of patients and aid them in returning to their daily activities with ease is one of the major factors augmenting the global analgesics market demand to manage surgery-related pain. Abdominal hysterectomy is the most common gynecological surgery performed in the United States.

Furthermore, the rising prevalence of chronic diseases and disorders is also boosting the global analgesics market growth. Patients suffering from chronic conditions that often are lifelong prefer non-invasive alternatives to effectively manage their pain due to the frequent requirement of appropriate therapies. Non-invasive pain relief methods provide ease of use to the patients, which is vital in cases where the patients might require frequent pain relief. Meanwhile, the growth of the geriatric population is also propelling the demand for the analgesics market, as the older population is more prone to falling ill and getting injured due to lack of coordination.

Additionally, the government and regulatory bodies across the globe are increasingly working on boosting the development of non-opioid alternatives for opioid-based analgesics that have been traditionally used for managing pain in cases of surgeries and chronic health conditions, positively influencing the market's expansion by ensuring the increased availability of non-opioid analgesics. In February 2022, the U.S. Food and Drug Administration (FDA) unveiled new steps to foster the development of alternatives to opioids that are non-addictive for decreasing exposure to opioids and managing acute pain. As part of the United States Department of Health and Human Services' Five-Point Strategy to combat the opioid crisis, the FDA is addressing the epidemic on all fronts and significantly focusing on preventing new addictions and decreasing exposure to opioids by taking measures to encourage appropriate prescribing and promoting the development of improved pain relief solutions.

Increasing Cases of Chronic Conditions Boost Market Demand

The rising cases of chronic diseases and injuries are one of the major factors propelling the requirement for different types of analgesics. As per the estimates of the Christopher & Dana Reeve Foundation, approximately 18,000 new cases of spinal cord injury are reported in the United States every year. This increase in cases of spinal cord injuries is augmenting the requirement for various pain management solutions, including analgesics. Neuropathic or nerve pain is most common in cases of spinal cord injuries and is often described as a tight, burning, aching, or squeezing pain. Additionally, patients with spinal cord injuries also often suffer from musculoskeletal pain in the area above the injury, thus increasing the reliance on analgesics for pain relief. Moreover, the rising cases of cancer, among other chronic diseases, are also increasing the requirement for analgesics. Individuals with cancer experience pain due to the cancer treatment, the cancer itself, or a combination of both. Pain can arise from varying sources, and the pain relief offered depends upon the severity and type of pain, along with the general level of fitness and health of the patient. In cases of severe cancer pain, fast-acting opioids, fentanyl, or morphine are commonly used.

Rising Requirement for Surgical Procedures Supports Market Expansion

The growing requirement for surgical procedures for treating and managing various health conditions is boosting the requirement for different types of analgesics to manage postoperative pain. The estimated increase in the requirement for surgical procedures can be attributed to increasing incidences of road traffic accidents, metabolic diseases, and rising cases of cardiovascular disorders. According to the estimates of the U.S. Centers for Disease Control and Prevention, in 2022, approximately 702,880 people died from heart disease in the United States. This increase and the severe nature of the condition are augmenting the requirement for surgical interventions and propelling the reliance on analgesics for managing surgical pain. Postoperative pain control aids patients in transitioning smoothly back to their normal functions and is essential for reducing the various negative consequences associated with acute postsurgical pain, thus increasing the requirement for opioid analgesics and providing lucrative growth opportunities to the market.

Traditionally, opioid analgesic therapy has been used for treating acute postoperative pain. However, concerns about the misuse of opioids are bolstering the demand for research activities to support the development of pain treatment strategies that focus on using a multimodal pain management approach.

Retail Pharmacies Hold Significant Market Share

The expansion of the segment can be attributed to the increasing generation of prescriptions for analgesics due to the growing prevalence of chronic conditions, increasing cases of injuries, and rapid growth of the geriatric population. Additionally, the increasing launch of over-the-counter (OTC) analgesics contributes to the significant presence of retail pharmacies.

Meanwhile, online pharmacies are expected to witness significant growth over the forecast period due to the different advantages they offer, including lucrative discounts, home delivery, and overnight shipping. Additionally, various online pharmacies are working on increasing the availability of same-day delivery services, further supporting the segment's expansion. In October 2024, Amazon Pharmacy of Amazon.com, Inc. announced their plans to double the number of cities where patients can get their medications on the same day. With the help of its advanced automation technology and vast logistics network, the company aims to solve some of the biggest issues of the pharmacy sector: affordable access to medications and lack of convenience.

North America Holds Major Market Share

The growth of the North American analgesics market can be attributed to the strong presence of key players in the region, the growth of the geriatric population, and rising cancer cases. As per the estimates of the National Cancer Institute, 2,001,140 new cases of cancer are expected to be diagnosed in the United States in 2024. This increase is propelling the requirement for analgesics in the country among cancer patients to manage the different types of cancer-related pains. Mild cancer pain is usually treated with non-opioid analgesics alone or in combination with opioids, whereas moderate to severe cancer pain is treated with strong opioids. Additionally, the growth of the market is supported by rising research and development activities that aim to create safer and more effective pain management therapies. The United States has been at the forefront of innovation, with a wide range of pharmaceutical companies in the country significantly investing in the development of novel drug delivery systems and non-opioid analgesics. Additionally, the increasing awareness about the different analgesics available for individuals living with chronic health conditions and growing efforts of the regulatory bodies in North America to increase the availability of non-opioid analgesics are also providing lucrative growth opportunities to the market.

Future Market Scenario (2024-2031F)

As per the global analgesics market analysis, the market is expected to witness significant growth over the forecast period due to rising cases of chronic diseases, increasing requirements for surgical intervention, and expansion of the geriatric population. The World Health Organization (WHO) estimates that by 2030, one in six people across the globe will be 60 or older. This growth is expected to propel the market's demand as the older population is more prone to getting sick and requires analgesics to manage pain. Furthermore, the advancements in drug delivery systems and increasing efforts to develop non-opioid pain medications are also expected to provide lucrative growth opportunities to the market.

Additionally, the demand for non-opioid analgesics is also expected to increase significantly in the coming years due to the global opioid crisis, because of which healthcare professionals are working on reducing opioid prescriptions. Regulatory bodies and governments are also supporting the efforts of pharmaceutical companies to innovate and develop new non-opioid formulations, providing lucrative growth opportunities to the market. Meanwhile, the rise in disposable incomes and growing awareness about the various options available for pain management are also expected to drive the demand for analgesics in different regions across the globe.

Key Players Landscape and Outlook

The market's key players are focusing on developing and launching new products to expand their market share. In March 2023, Pfizer Inc. announced that they had received approval from the U.S. FDA for ZAVZPRET, a calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray used for treating migraine. This approval marks a significant breakthrough for patients suffering from migraine who require freedom from pain to carry out their day-to-day tasks and prefer alternatives to oral medications. The introduction of the product also underscores the company's commitment to delivering novel treatment options to ensure patients with migraine receive relief. Such efforts are expected to aid the company in expanding its product portfolio and providing novel therapeutic solutions to patients worldwide.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Analgesics Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Drug Class
      • 4.2.1.1. Opioid
      • 4.2.1.2. Non-opioid
      • 4.2.1.3. Compound Medication
    • 4.2.2. By Route of Administration
      • 4.2.2.1. Oral
      • 4.2.2.2. Parenteral
      • 4.2.2.3. Topical
      • 4.2.2.4. Transdermal
      • 4.2.2.5. Others
    • 4.2.3. By Application
      • 4.2.3.1. Musculoskeletal Pain
      • 4.2.3.2. Dental Pain
      • 4.2.3.3. Surgical Pain
      • 4.2.3.4. Cancer Pain
      • 4.2.3.5. Neuropathic Pain
      • 4.2.3.6. Others
    • 4.2.4. By Distribution Channel
      • 4.2.4.1. Hospital Pharmacies
      • 4.2.4.2. Retail Pharmacies
      • 4.2.4.3. Online Pharmacies
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Drug Class
    • 4.3.2. By Route of Administration
    • 4.3.3. By Application
    • 4.3.4. By Distribution Channel
    • 4.3.5. By Region

5. North America Analgesics Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Drug Class
      • 5.2.1.1. Opioid
      • 5.2.1.2. Non-opioid
      • 5.2.1.3. Compound Medication
    • 5.2.2. By Route of Administration
      • 5.2.2.1. Oral
      • 5.2.2.2. Parenteral
      • 5.2.2.3. Topical
      • 5.2.2.4. Transdermal
      • 5.2.2.5. Others
    • 5.2.3. By Application
      • 5.2.3.1. Musculoskeletal Pain
      • 5.2.3.2. Dental Pain
      • 5.2.3.3. Surgical Pain
      • 5.2.3.4. Cancer Pain
      • 5.2.3.5. Neuropathic Pain
      • 5.2.3.6. Others
    • 5.2.4. By Distribution Channel
      • 5.2.4.1. Hospital Pharmacies
      • 5.2.4.2. Retail Pharmacies
      • 5.2.4.3. Online Pharmacies
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Analgesics Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Drug Class
          • 5.3.1.2.1.1. Opioid
          • 5.3.1.2.1.2. Non-opioid
          • 5.3.1.2.1.3. Compound Medication
        • 5.3.1.2.2. By Route of Administration
          • 5.3.1.2.2.1. Oral
          • 5.3.1.2.2.2. Parenteral
          • 5.3.1.2.2.3. Topical
          • 5.3.1.2.2.4. Transdermal
          • 5.3.1.2.2.5. Others
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Musculoskeletal Pain
          • 5.3.1.2.3.2. Dental Pain
          • 5.3.1.2.3.3. Surgical Pain
          • 5.3.1.2.3.4. Cancer Pain
          • 5.3.1.2.3.5. Neuropathic Pain
          • 5.3.1.2.3.6. Others
        • 5.3.1.2.4. By Distribution Channel
          • 5.3.1.2.4.1. Hospital Pharmacies
          • 5.3.1.2.4.2. Retail Pharmacies
          • 5.3.1.2.4.3. Online Pharmacies
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Analgesics Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Analgesics Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Analgesics Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Analgesics Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. AbbVie Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 21.3.2. Pfizer Inc.
    • 21.3.3. Endo, Inc.
    • 21.3.4. Eli Lilly and Company
    • 21.3.5. Bayer AG
    • 21.3.6. Abbott Laboratories
    • 21.3.7. Johnson & Johnson Services, Inc. (Janssen Global Services, LLC)
    • 21.3.8. GlaxoSmithKline plc
    • 21.3.9. Teva Pharmaceutical Industries Ltd.
    • 21.3.10. Groupe Sanofi

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 3. Global Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 4. Global Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 6. Global Analgesics Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 8. North America Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 9. North America Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 10. North America Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 12. North America Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 14. United States Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 15. United States Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 16. United States Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 18. Canada Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 19. Canada Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 20. Canada Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 21. Canada Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 23. Mexico Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Mexico Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 25. Mexico Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 26. Mexico Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 28. Europe Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Europe Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 30. Europe Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 31. Europe Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 33. Europe Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 35. Germany Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 36. Germany Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 37. Germany Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 39. France Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 40. France Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 41. France Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 42. France Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 43. France Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 44. Italy Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Italy Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 46. Italy Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 47. Italy Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 49. United Kingdom Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 50. United Kingdom Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 51. United Kingdom Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 52. United Kingdom Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 54. Russia Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 55. Russia Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 56. Russia Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 57. Russia Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 59. Netherlands Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 60. Netherlands Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 61. Netherlands Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 62. Netherlands Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 64. Spain Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Spain Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 66. Spain Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 67. Spain Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 69. Turkey Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Turkey Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 71. Turkey Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 72. Turkey Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 74. Poland Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Poland Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 76. Poland Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 77. Poland Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 79. South America Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 80. South America Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 81. South America Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 82. South America Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 84. South America Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 86. Brazil Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 87. Brazil Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 88. Brazil Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 90. Argentina Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Argentina Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 92. Argentina Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 93. Argentina Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 95. Asia-Pacific Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 97. Asia-Pacific Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 98. Asia-Pacific Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 100. Asia-Pacific Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 101. India Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. India Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 103. India Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 104. India Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 105. India Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 106. China Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. China Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 108. China Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 109. China Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 110. China Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 111. Japan Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 112. Japan Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 113. Japan Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 114. Japan Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 116. Australia Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 117. Australia Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 118. Australia Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 119. Australia Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 121. Vietnam Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 122. Vietnam Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 123. Vietnam Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 124. Vietnam Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 126. South Korea Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. South Korea Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 128. South Korea Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 129. South Korea Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 131. Indonesia Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Indonesia Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 133. Indonesia Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 134. Indonesia Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 136. Philippines Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 137. Philippines Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 138. Philippines Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 139. Philippines Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 141. Middle East & Africa Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 143. Middle East & Africa Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 144. Middle East & Africa Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 146. Middle East & Africa Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 149. Saudi Arabia Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 150. Saudi Arabia Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 152. UAE Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 153. UAE Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 154. UAE Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 155. UAE Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 157. South Africa Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 158. South Africa Analgesics Market Share (%), By Drug Class, 2017-2031F
  • Figure 159. South Africa Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 160. South Africa Analgesics Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 162. By Drug Class Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023